QCLVX
Price
$34.10
Change
+$0.22 (+0.65%)
Updated
Jul 3 closing price
Net Assets
1.76B
VVIAX
Price
$70.10
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

QCLVX vs VVIAX

Header iconQCLVX vs VVIAX Comparison
Open Charts QCLVX vs VVIAXBanner chart's image
Federated Hermes MDT Large Cap Value C
Price$34.10
Change+$0.22 (+0.65%)
VolumeN/A
Net Assets1.76B
Vanguard Value Index Adm
Price$70.10
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
QCLVX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
QCLVX vs. VVIAX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QCLVX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 189B vs. QCLVX (1.76B). VVIAX pays higher dividends than QCLVX: VVIAX (2.18) vs QCLVX (0.19). QCLVX was incepted earlier than VVIAX: QCLVX (8 years) vs VVIAX (25 years). QCLVX (1.92) is less costly to investors than VVIAX (0.05). QCLVX is a more actively managed with annual turnover of: 69.00 vs. VVIAX (9.00). QCLVX has a lower initial minimum investment than VVIAX: QCLVX (1500) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 12.03 vs. QCLVX (6.94). VVIAX return over 5 years is better than : 80.13 vs. QCLVX (42.16).
QCLVXVVIAXQCLVX / VVIAX
Total Expense Ratio1.810.053,620%
Annual Report Gross Expense Ratio1.920.053,840%
Fund Existence8 years25 years-
Gain YTD10.4326.198168%
Front LoadN/AN/A-
Min. Initial Investment1500300050%
Min. Initial Investment IRAN/AN/A-
Net Assets1.76B189B1%
Annual Yield % from dividends0.192.189%
Returns for 1 year6.9412.0358%
Returns for 3 years24.8435.1771%
Returns for 5 years42.1680.1353%
Returns for 10 yearsN/A115.67-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CAVA86.523.81
+4.61%
CAVA Group
ADTN9.560.16
+1.70%
ADTRAN Holdings
TWST38.170.49
+1.30%
Twist Bioscience Corp
ATMC11.84N/A
N/A
AlphaTime Acquisition Corp
SCNI2.20-0.07
-2.95%
Scinai Immunotherapeutics Ltd.